# Stage 5.1 closure/hardening review

## Scope and evidence baseline

Review-only assessment of the veterinarian visit workspace, its portal proxies,
effective-session UX gates, backend capability authority and focused Chromium
coverage. Baseline evidence remains: Stage 5.1A read suite 5/5 PASS, Stage
5.1B completion suite 8/8 PASS, Node 22 typecheck/build PASS.

## Final architecture and invariant matrix

| Layer | Read workspace | Complete visit |
|---|---|---|
| Server route shell | Authenticated clinic session | Authenticated clinic session |
| Frontend UX gate | `clinical.visit.workspace.read` plus clinic/location scope | `clinical.visit.complete` plus scope and `CONFIRMED` |
| Portal proxy | Bearer forwarding; detail validates UUID | Bearer forwarding; validates hold ID and summary minimum |
| Backend authority | Role/capability/scopes/membership/resource | Role/capability/scopes/membership/state |
| Data | Exact eight-field visit projection | Existing completion response |
| Request suppression | No protected read without UX gate | No POST without mutation gate |

The reviewed implementation conforms to this matrix. Route shells establish only
an authenticated-session boundary; they do not manufacture a capability. The
backend evaluator remains authoritative for direct authenticated proxy calls.

## Authorization review

`CLINIC_VETERINARIAN` is accepted by the clinic shell. Navigation and V50 use
the server-derived effective session; read capability or scope loss suppresses
list/detail requests, and completion capability/scope/state loss suppresses the
POST. `CLINIC_ADMIN` has no backend `clinical.visit.complete` grant. Proxies do
not accept frontend capability values. User-facing read 401/403/404 states and
completion 401/403 errors are normalized without internal denial payloads.

## Data-minimization and DTO review

Backend read contract and portal parser use the approved fields only:
`holdId`, `clinicId`, `locationId`, `scheduledStart`, `scheduledEnd`, `status`,
`petDisplayName`, `species`. No owner/contact, assignment or administration
fields are introduced; proxies add no envelope. Parser rejects unknown/missing
keys and non-string fields.

## Mutation correctness and accessibility review

Completion is rendered only for scoped `clinical.visit.complete` and
`CONFIRMED`. Client validation protects 3–8000 characters, including injected
over-limit input. Pending disables and renames the submit control; `finally`
releases deferred test responses. Success/conflict perform one controlled
refresh, while validation/403/5xx/network paths preserve summary and do not
retry automatically. Errors return focus to the labelled summary field; the
error is described by `aria-describedby`, and completion uses one meaningful
`role="status"` message. Focus cannot remain on the removed submit button.
Focused axe checks are scoped to the form and detail container.

## Proxy/runtime-config and test-quality review

No production diagnostics, mock marker, Playwright port or `VETHELP_PROXY_DIAGNOSTICS`
code remains in the portal. List/detail/completion forward session Authorization;
detail/completion use UUID v1–v5 validation. Focused tests have no `.skip`,
`.only` or timeout sleeps; their deferred pending mock releases in `finally`,
matrix fixtures reset state per iteration, and request counters distinguish
initial detail reads from post-mutation refreshes.

## Findings

- P0: none.
- P1: closed. `parseVeterinarianVisit` now accepts only `CONFIRMED | COMPLETED`
  and validates RFC3339 timestamps semantically: timezone is mandatory,
  calendar/offset components are checked, and parsing must be finite. Timestamp
  ordering was not added because `scheduledEnd > scheduledStart` is not an
  established frontend DTO invariant.
- P2: none.

## Repairs applied

None in this review.

## Deferred follow-up

None for Stage 5.1.

## Verification evidence and recommendation

Node 22 typecheck/build passed after parser hardening. The focused veterinarian
read suite passed 6/6 and the completion regression suite passed 8/8.

**Review result: APPROVED.** There are no open Stage 5.1 P0/P1 findings; the
stage is hardened. Next stage: select the next product slice separately from
Stage 5.1 technical debt.
